Process View
A fatty acid oxidation process in which the methyl group at the end of the fatty acid molecule (the omega carbon) is first oxidized to a hydroxyl group, then to an oxo group, and finally to a carboxyl group. The long chain dicarboxylates derived from omega-oxidation then enter the beta-oxidation pathway for further degradation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "fatty acid omega oxidation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.999 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.950 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.934 | Human | |
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.853 | Human | |
| ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.835 | Human | |
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.833 | Human | |
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.781 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.519 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.438 | Human | |
| C6 | complement component 6 | 0.369 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.294 | Human | |
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.240 | ||
| ANGPTL3 | angiopoietin-like 3 | 0.215 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.211 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.208 | ||
| ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | 0.197 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.191 | ||
| C8A | complement component 8, alpha polypeptide | 0.157 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.153 | ||
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.140 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.139 | ||
| KNG1 | kininogen 1 | 0.133 | ||
| ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 0.131 | ||
| ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.130 | ||
| PLG | plasminogen | 0.117 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.110 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.109 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.108 | ||
| PAH | phenylalanine hydroxylase | 0.106 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.106 | ||
| OTC | ornithine carbamoyltransferase | 0.105 | ||
| UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.098 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.078 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.078 | ||
| FMO4 | flavin containing monooxygenase 4 | 0.077 | ||
| ASPA | aspartoacylase | 0.076 | ||
| C7 | complement component 7 | 0.076 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.074 | ||
| CDHR5 | cadherin-related family member 5 | 0.067 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.064 | ||
| SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.057 | ||
| GSTA3 | glutathione S-transferase alpha 3 | 0.057 | ||
| FMO3 | flavin containing monooxygenase 3 | 0.057 | ||
| DIO1 | deiodinase, iodothyronine, type I | 0.055 | ||
| CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 0.053 | Human | |
| F9 | coagulation factor IX | 0.052 | ||
| SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 | 0.051 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.049 | ||
| HAL | histidine ammonia-lyase | 0.046 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.046 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.046 | ||
| FMO2 | flavin containing monooxygenase 2 (non-functional) | 0.045 | ||
| NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.044 | ||
| ANXA13 | annexin A13 | 0.041 | ||
| HRG | histidine-rich glycoprotein | 0.041 | ||
| ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 | 0.040 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.039 | ||
| GLYAT | glycine-N-acyltransferase | 0.038 | ||
| OGN | osteoglycin | 0.037 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.037 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.036 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.036 | ||
| SCGB2A1 | secretoglobin, family 2A, member 1 | 0.035 | ||
| C8B | complement component 8, beta polypeptide | 0.035 | ||
| HGD | homogentisate 1,2-dioxygenase | 0.035 | ||
| PLIN1 | perilipin 1 | 0.035 | ||
| PRLR | prolactin receptor | 0.034 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.034 | Human | |
| DEFB1 | defensin, beta 1 | 0.033 | ||
| KRT13 | keratin 13 | 0.033 | ||
| KRT4 | keratin 4 | 0.032 | ||
| MTTP | microsomal triglyceride transfer protein | 0.031 | ||
| PIP | prolactin-induced protein | 0.030 | ||
| ARG1 | arginase, liver | 0.030 | ||
| SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.029 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.029 | ||
| CLDN8 | claudin 8 | 0.029 | ||
| EPHX2 | epoxide hydrolase 2, cytoplasmic | 0.028 | ||
| FABP2 | fatty acid binding protein 2, intestinal | 0.028 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.028 | ||
| AOX1 | aldehyde oxidase 1 | 0.028 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.027 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.027 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.026 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.025 | ||
| ACSM5 | acyl-CoA synthetase medium-chain family member 5 | 0.025 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.025 | ||
| BBOX1 | butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | 0.024 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.024 | ||
| ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 0.024 | Human | |
| C10orf116 | chromosome 10 open reading frame 116 | 0.024 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.023 | ||
| CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 0.023 | ||
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.023 | ||
| CFHR4 | complement factor H-related 4 | 0.023 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.023 | ||
| ADIPOQ | adiponectin, C1Q and collagen domain containing | 0.022 | ||
| C9orf68 | chromosome 9 open reading frame 68 | 0.022 | ||
| DAO | D-amino-acid oxidase | 0.022 | ||
| FETUB | fetuin B | 0.022 | ||
| F5 | coagulation factor V (proaccelerin, labile factor) | 0.022 | ||
| APOF | apolipoprotein F | 0.021 | ||
| C4BPB | complement component 4 binding protein, beta | 0.021 | ||
| ACADL | acyl-CoA dehydrogenase, long chain | 0.020 | ||
| AKR1B10 | aldo-keto reductase family 1, member B10 (aldose reductase) | 0.020 | ||
| NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.019 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.019 | ||
| SERPINB13 | serpin peptidase inhibitor, clade B (ovalbumin), member 13 | 0.019 | ||
| CLCA2 | chloride channel accessory 2 | 0.019 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.019 | ||
| SCGB1D2 | secretoglobin, family 1D, member 2 | 0.019 | ||
| FLG | filaggrin | 0.019 | ||
| LRRC31 | leucine rich repeat containing 31 | 0.019 | ||
| SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 0.019 | ||
| CLCA4 | chloride channel accessory 4 | 0.018 | ||
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.018 | ||
| MAOA | monoamine oxidase A | 0.018 | ||
| ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 0.018 | ||
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.018 | ||
| AFM | afamin | 0.018 | ||
| ADRA1A | adrenergic, alpha-1A-, receptor | 0.018 | ||
| CRISP2 | cysteine-rich secretory protein 2 | 0.018 | ||
| UPK1B | uroplakin 1B | 0.018 | ||
| FMO5 | flavin containing monooxygenase 5 | 0.017 | ||
| SLC26A3 | solute carrier family 26, member 3 | 0.017 | ||
| ANXA10 | annexin A10 | 0.017 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.017 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.017 | ||
| HHLA2 | HERV-H LTR-associating 2 | 0.017 | ||
| APOD | apolipoprotein D | 0.017 | ||
| ATP10B | ATPase, class V, type 10B | 0.017 | ||
| PSCA | prostate stem cell antigen | 0.017 | ||
| POF1B | premature ovarian failure, 1B | 0.017 | ||
| DPYS | dihydropyrimidinase | 0.017 | ||
| CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 | 0.016 | Human | |
| CES1 | carboxylesterase 1 | 0.016 | ||
| LAMA2 | laminin, alpha 2 | 0.016 | ||
| UNC93A | unc-93 homolog A (C. elegans) | 0.016 | ||
| BHMT2 | betaine--homocysteine S-methyltransferase 2 | 0.016 | ||
| DPT | dermatopontin | 0.016 | ||
| VTCN1 | V-set domain containing T cell activation inhibitor 1 | 0.016 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.016 | ||
| TMC5 | transmembrane channel-like 5 | 0.015 | ||
| POU1F1 | POU class 1 homeobox 1 | 0.015 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.015 | ||
| SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 | 0.015 | ||
| MAOB | monoamine oxidase B | 0.015 | ||
| CRISP3 | cysteine-rich secretory protein 3 | 0.015 | ||
| NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | 0.015 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.015 | ||
| GSTT1 | glutathione S-transferase theta 1 | 0.014 | ||
| C5orf4 | chromosome 5 open reading frame 4 | 0.014 | ||
| OMD | osteomodulin | 0.014 | ||
| ACOX2 | acyl-CoA oxidase 2, branched chain | 0.014 | ||
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.014 | ||
| CYP4A22 | cytochrome P450, family 4, subfamily A, polypeptide 22 | 0.014 | Human | |
| MSMB | microseminoprotein, beta- | 0.014 | ||
| C2orf54 | chromosome 2 open reading frame 54 | 0.014 | ||
| C1orf129 | chromosome 1 open reading frame 129 | 0.014 | ||
| SGK2 | serum/glucocorticoid regulated kinase 2 | 0.013 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.013 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.013 | ||
| GPX2 | glutathione peroxidase 2 (gastrointestinal) | 0.013 | ||
| PIK3C2G | phosphoinositide-3-kinase, class 2, gamma polypeptide | 0.013 | ||
| CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 0.013 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.013 | Human | |
| RGN | regucalcin (senescence marker protein-30) | 0.013 | ||
| AGR2 | anterior gradient homolog 2 (Xenopus laevis) | 0.013 | ||
| PIPOX | pipecolic acid oxidase | 0.013 | ||
| GHR | growth hormone receptor | 0.013 | ||
| SPINK1 | serine peptidase inhibitor, Kazal type 1 | 0.012 | ||
| APOC3 | apolipoprotein C-III | 0.012 | ||
| DSG1 | desmoglein 1 | 0.012 | ||
| HFE2 | hemochromatosis type 2 (juvenile) | 0.012 | ||
| LIPC | lipase, hepatic | 0.012 | ||
| UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | 0.012 | ||
| RERGL | RERG/RAS-like | 0.012 | ||
| TIMP4 | TIMP metallopeptidase inhibitor 4 | 0.012 | ||
| ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 | 0.012 | ||
| CPS1 | carbamoyl-phosphate synthase 1, mitochondrial | 0.012 | ||
| TSPAN8 | tetraspanin 8 | 0.012 | ||
| GYS2 | glycogen synthase 2 (liver) | 0.012 | ||
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.012 | ||
| CHL1 | cell adhesion molecule with homology to L1CAM (close homolog of L1) | 0.012 | ||
| CHRDL1 | chordin-like 1 | 0.012 | ||
| UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 | 0.012 | ||
| SEMG2 | semenogelin II | 0.012 | ||
| TMEM40 | transmembrane protein 40 | 0.012 | ||
| MOSC1 | MOCO sulphurase C-terminal domain containing 1 | 0.012 | ||
| SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 0.012 | ||
| TTPA | tocopherol (alpha) transfer protein | 0.012 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.011 | ||
| CYP27A1 | cytochrome P450, family 27, subfamily A, polypeptide 1 | 0.011 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.011 | ||
| REG3G | regenerating islet-derived 3 gamma | 0.011 | ||
| ZNF214 | zinc finger protein 214 | 0.011 | ||
| PON3 | paraoxonase 3 | 0.011 | ||
| CCL16 | chemokine (C-C motif) ligand 16 | 0.011 | ||
| VIL1 | villin 1 | 0.011 | ||
| FHL5 | four and a half LIM domains 5 | 0.011 | ||
| MUC13 | mucin 13, cell surface associated | 0.011 | ||
| ABP1 | amiloride binding protein 1 (amine oxidase (copper-containing)) | 0.011 | ||
| GPR110 | G protein-coupled receptor 110 | 0.011 | ||
| LRRC19 | leucine rich repeat containing 19 | 0.011 | ||
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.011 | ||
| FCGBP | Fc fragment of IgG binding protein | 0.011 | ||
| CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 | 0.011 | ||
| ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.011 | ||
| SLC5A12 | solute carrier family 5 (sodium/glucose cotransporter), member 12 | 0.011 | ||
| METTL7A | methyltransferase like 7A | 0.011 | ||
| HNF4G | hepatocyte nuclear factor 4, gamma | 0.011 | ||
| SCEL | sciellin | 0.011 | ||
| BCAS1 | breast carcinoma amplified sequence 1 | 0.010 | ||
| IL20RA | interleukin 20 receptor, alpha | 0.010 | ||
| TTC22 | tetratricopeptide repeat domain 22 | 0.010 | ||
| CLRN3 | clarin 3 | 0.010 | ||
| OSGIN1 | oxidative stress induced growth inhibitor 1 | 0.010 | ||
| GPR128 | G protein-coupled receptor 128 | 0.010 | ||
| NTS | neurotensin | 0.010 | ||
| AGTR1 | angiotensin II receptor, type 1 | 0.010 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.010 | ||
| AQP7 | aquaporin 7 | 0.010 | ||
| CFD | complement factor D (adipsin) | 0.010 | ||
| UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 0.010 |